Jörg B. Schulz

Active 1993–2026

218
Papers
35,951
Citations
103
h-index
207
i10-index

Citations

Citations per year for Jörg B. Schulz1967: 4 citations1993: 1 citations1994: 10 citations1995: 28 citations1996: 68 citations1997: 109 citations1998: 175 citations1999: 213 citations2000: 232 citations2001: 228 citations2002: 261 citations2003: 354 citations2004: 316 citations2005: 310 citations2006: 375 citations2007: 349 citations2008: 401 citations2009: 407 citations2010: 372 citations2011: 409 citations2012: 390 citations2013: 401 citations2014: 347 citations2015: 337 citations2016: 319 citations2017: 344 citations2018: 320 citations2019: 945 citations2020: 864 citations2021: 897 citations2022: 726 citations2023: 526 citations2024: 751 citations2025: 314 citations2026: 25 citations1968–1992: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,153 citing papers, 24.9% of this breakdownGermany: 1,583 citing papers, 9.5% of this breakdownUnited Kingdom: 1,473 citing papers, 8.9% of this breakdownItaly: 882 citing papers, 5.3% of this breakdownChina: 856 citing papers, 5.1% of this breakdownCanada: 640 citing papers, 3.8% of this breakdownFrance: 557 citing papers, 3.4% of this breakdownJapan: 516 citing papers, 3.1% of this breakdownAustralia: 499 citing papers, 3% of this breakdownSpain: 494 citing papers, 3% of this breakdownNetherlands: 436 citing papers, 2.6% of this breakdownSweden: 386 citing papers, 2.3% of this breakdown
0%24.9%Other 25.1%

Fields

  • Medicine52.2%
  • Neuroscience22.7%
  • Biochemistry, Genetics and Molecular Biology19.4%
  • Psychology1.1%
  • Immunology and Microbiology0.8%
  • Computer Science0.6%
  • Other3.2%

Topics

  • Parkinson's Disease Mechanisms and Treatments8%
  • Alzheimer's disease research and treatments5%
  • Genetic Neurodegenerative Diseases3.6%
  • Mitochondrial Function and Pathology3.4%
  • Dementia and Cognitive Impairment Research3.2%
  • Amyotrophic Lateral Sclerosis Research2.8%
  • Other74%

Coauthors

All papers

Open in search
  1. Diagnosis and management of dementia with Lewy bodies

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kenji Kosaka, V.M.Y. Lee, Andrew J. Lees, Irene Litvan, Elisabet Londos, Oscar L. López, Satoshi Minoshima, Y Mizuno, J. A. Molina, Elizabeta B. Mukaetova‐Ladinska, Florence Pasquier, R. H. Perry, Jörg B. Schulz, John Q. Trojanowski, Masahito Yamada - Neurology 2005 cited by 5,057

  2. Modelling neural correlates of working memory: A coordinate-based meta-analysis

    Authors: , , , , , , , - NeuroImage 2011 cited by 989

  3. Long COVID‐19: Objectifying most self‐reported neurological symptoms

    Authors: , , , , , , , , , , , , - Annals of Clinical and Translational Neurology 2022 cited by 132

  4. Video-Based Hand Movement Analysis of Parkinson Patients before and after Medication Using High-Frame-Rate Videos and MediaPipe

    Authors: , , , , , , - Sensors 2022 cited by 68

  5. Current and experimental treatments of Parkinson disease: A guide for neuroscientists

    Authors: , - Journal of Neurochemistry 2016 cited by 358

  6. Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jun-Suk Kang, Massimo Pandolfo, Jörg B. Schulz, Sonia Molho, Alhassane Diallo, Thomas Klockgether - The Lancet Neurology 2015 cited by 299

  7. Senataxin, the ortholog of a yeast RNA helicase, is mutant in ataxia-ocular apraxia 2

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jorge Sequeiros, Alexandra Dürr, Jean‐Marie Warter, Michel Kœnig - Nature Genetics 2004 cited by 521

  8. Intensive speech and language therapy in patients with chronic aphasia after stroke: a randomised, open-label, blinded-endpoint, controlled trial in a health-care setting

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Georg Goldenberg, Gudrun Klingenberg, Eberhard König, F. Müller, B.F. Gröne, Stefan Knecht, Ricarda Baake, Janet Knauss, S Miethe, U Steller, R Sudhoff, E Schillikowski, G. Pfeiffer, K Billo, Henry Hoffmann, F-J Ferneding, Sören Runge, Taylor Keck, V Middeldorf, Steffen Krüger, Ben Wilde, Karsten Krakow, Christopher R. Berghoff, F Reinhuber, Ingeborg Maser, Werner Hofmann, Christa Sous-Kulke, W. Schupp, A Oertel, Dan M. Batz, Farsin Hamzei, Karen Schulz, Anna Maria Meyer, A Kartmann, O'N Som, S-B Schipke, S. Bamborschke - The Lancet 2017 cited by 375

  9. Glutathione, oxidative stress and neurodegeneration

    Authors: , , , - European Journal of Biochemistry 2000 cited by 1,226

  10. Cerebral changes improved by physical activity during cognitive decline: A systematic review on MRI studies

    Authors: , , , - NeuroImage Clinical 2019 cited by 123

  11. Pre‐fibrillar α‐synuclein variants with impaired β‐structure increase neurotoxicity in Parkinson's disease models

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - The EMBO Journal 2009 cited by 446

  12. Drosophila melanogaster as a model organism for Alzheimer’s disease

    Authors: , , - Molecular Neurodegeneration 2013 cited by 269

  13. The natural history of spinocerebellar ataxia type 1, 2, 3, and 6

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Chantal Depondt, Massimo Pandolfo, J.-S. Kang, Susanne Ratzka, Jörg B. Schulz, Sophie Tézenas du Montcel, Thomas Klockgether - Neurology 2011 cited by 228

  14. Progression characteristics of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS): a 4-year cohort study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mario Fichera, Francesc Palau, Mar O’Callaghan, Marie Biet, Marie Lorraine Monin, Andreas Eigentler, Elisabetta Indelicato, Matthias Amprosi, Florentine Radelfahr, A. Bischoff, Florian Holtbernd, Nikolina Brčina, Christian Hohenfeld, Georgios Koutsis, Marianthi Breza, Enrico Bertini, Gessica Vasco - The Lancet Neurology 2021 cited by 97

  15. Responsiveness of different rating instruments in spinocerebellar ataxia patients

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Neurology 2010 cited by 190

  16. Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease

    Authors: , , , , , , , , , , , , , , - Human Molecular Genetics 2005 cited by 566

  17. Biological and clinical characteristics of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS) cohort: a cross-sectional analysis of baseline data

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Neurology 2015 cited by 211

  18. Going beyond the mean: Intraindividual variability of cognitive performance in prodromal and early neurodegenerative disorders

    Authors: , , , - The Clinical Neuropsychologist 2019 cited by 105

  19. Neurofilaments in spinocerebellar ataxia type 3: blood biomarkers at the preataxic and ataxic stage in humans and mice

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Elke Stransky, Kathrin Brockmann, Jörg B. Schulz, László Balikó, Judith van Gaalen, Mafalda Raposo, Andreas Jeromin - EMBO Molecular Medicine 2020 cited by 102

  20. Cognitive decline in Parkinson’s disease: the impact of the motor phenotype on cognition

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Neurology Neurosurgery & Psychiatry 2018 cited by 87

  21. Brain Structure and Degeneration Staging in Friedreich Ataxia: Magnetic Resonance Imaging Volumetrics from the ENIGMA‐Ataxia Working Group

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Denis Peruzzo, Pramod Kumar Pisharady, Giuseppe Pontillo, Kathrin Reetz, Thiago Junqueira Ribeiro de Rezende, Sandro Romanzetti, Francesco Saccà, Christoph Scherfler, Jörg B. Schulz, Ambra Stefani, Claudia Testa, Sophia I. Thomopoulos, Dagmar Timmann, Stefania Tirelli, Caterina Tonon, Marinela Vavla, Gary F. Egan, Paul M. Thompson - Annals of Neurology 2021 cited by 66

  22. Frailty is an outcome predictor in patients with acute ischemic stroke receiving endovascular treatment

    Authors: , , , , , , - Age and Ageing 2021 cited by 49

  23. Erythropoietin Abrogates Post-Ischemic Activation of the NLRP3, NLRC4, and AIM2 Inflammasomes in Microglia/Macrophages in a TAK1-Dependent Manner

    Authors: , , , , , , , , , , , - Translational Stroke Research 2021 cited by 37

  24. Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with IκBα induction and block of NFκB and iNOS activation

    Authors: , , , , - Journal of Neurochemistry 2003 cited by 382